Attenuated Toxoplasma gondii ts-4 mutants engineered to express the Leishmania antigen KMP-11 elicit a specific immune response in BALB/c mice.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Vaccine

• Publication date

  2001-11-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0264-410X(01)00341-3PMID 11672909
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The humoral immune response to the kinetoplastid membrane protein-11 in patients with American leishmaniasis and Chagas disease: prevalence of IgG subclasses and mapping of epitopes.

  2000cited by this paper
• Listeria monocytogenes as a Short-Lived Delivery System for the Induction of Type 1 Cell-Mediated Immunity against the p36/LACK Antigen of Leishmania major

  2000cited by this paper
• Recombinant Attenuated Toxoplasma gondii Expressing the Plasmodium yoelii Circumsporozoite Protein Provides Highly Effective Priming for CD8+ T Cell-Dependent Protective Immunity Against Malaria1

  2000cited by this paper
• Antigen‐pulsed epidermal Langerhans cells protect susceptible mice from infection with the intracellular parasite Leishmania major

  1998cited by this paper
• The Protozoan Parasite Toxoplasma gondii Targets Proteins to Dense Granules and the Vacuolar Space Using Both Conserved and Unusual Mechanisms

  1998cited by this paper
• Processing of Toxoplasma ROP1 protein in nascent rhoptries.

  1998cited by this paper
• Genetic Immunization with Glycoprotein 63 cDNA Results in a Helper T Cell Type 1 Immune Response and Protection in a Murine Model of Leishmaniasis

  1998cited by this paper
• Cloning of genes and expression and antigenicity analysis of the Leishmania infantum KMP-11 protein.

  1997cited by this paper
• Vaccination with DNA Encoding the Immunodominant LACK Parasite Antigen Confers Protective Immunity to Mice Infected with Leishmania major

  1997cited by this paper
• Leishmania vaccines: old and new.

  1997cited by this paper
• Intact immune defenses are required for mice to resist the ts-4 vaccine strain of Toxoplasma gondii

  1996cited by this paper
• Leishmaniasis: Immunological and clinical aspects and vaccines in Venezuela.

  1996cited by this paper
• Invasion, control and persistence of Leishmania parasites.

  1996cited by this paper
• Expression cloning of a protective Leishmania antigen.

  1995cited by this paper
• Vaccines against leishmaniasis.

  1995cited by this paper
• The regulation of immunity to Leishmania major.

  1995cited by this paper
• The kinetoplastid membrane protein 11 of Leishmania donovani and African trypanosomes is a potent stimulator of T-lymphocyte proliferation

  1994cited by this paper
• Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection

  1993cited by this paper
• Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response

  1993cited by this paper
• Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63.

  1993cited by this paper
• Transient transfection and expression in the obligate intracellular parasite Toxoplasma gondii

  1993cited by this paper
• Gene replacement in Toxoplasma gondii with chloramphenicol acetyltransferase as selectable marker.

  1993cited by this paper
• Stimulation of human T lymphocytes by Leishmania lipophosphoglycan-associated proteins.

  1992cited by this paper
• Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine.

  1991cited by this paper
• Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis.

  1990cited by this paper
• Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes.

  1988cited by this paper
• Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice.

  1986cited by this paper
• Live and killed vaccines against toxoplasmosis in mice.

  1983cited by this paper
• Toxoplasma gondii: isolation and preliminary characterization of temperature-sensitive mutants.

  1976cited by this paper

• Development of dominant epitope-based vaccines encoding Gp63, Kmp-11 and Amastin against visceral leishmaniasis.

  2021cites this paper
• Vaccination in Leishmaniasis: A Review Article

  2021cites this paper
• The immunity of the recombinant prokaryotic and eukaryotic subunit vaccines against cutaneous leishmaniasis.

  2021cites this paper
• Design, Construction and Immunogenicity Assessment of pEGFP-N1-KMP11-GP96 (Fusion) as a DNA Vaccine Candidate against Leishmania major Infection in BALB/c Mice

  2020cites this paper
• Evaluation of a new live recombinant vaccine against cutaneous leishmaniasis in BALB/c mice

  2020cites this paper
• Cloning and molecular characterization of thiol-specific antioxidant gene of Leishmania tropica Turkey isolate

  2019cites this paper
• Drug Resistance in Leishmania Parasites

  2018cites this paper
• Leishmaniasis in humans: drug or vaccine therapy?

  2017cites this paper
• Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasis

  2017cites this paper
• Vacunas contra Leishmania

  2016cites this paper
• Expression of Babesia gibsoni thrombospondin-related adhesive protein in Toxoplasma gondii and evaluation of its antigenicity and immunogenicity

  2016cites this paper
• Immunogenicity and Efficacy of Live L. tarentolae Expressing KMP11-NTGP96-GFP Fusion as a Vaccine Candidate against Experimental Visceral Leishmaniasis Caused by L. infantum

  2016cites this paper
• Kinetoplastid Membrane Protein-11 as a Vaccine Candidate and a Virulence Factor in Leishmania

  2015cites this paper
• Identifying vaccine targets for anti-leishmanial vaccine development

  2014influential citation
• Vaccination as a Control Measure

  2013cites this paper
• Recombinant therapeutic protein vaccines.

  2013cites this paper
• MOLECULAR CLONING AND EXPRESSION OF THE LEISHMANIA INFANTUM KMP-11 GENE

  2013cites this paper
• Leishmaniasis: recombinant DNA vaccination and different approaches for vaccine development

  2013cites this paper
• Selection of novel antigens from Leishmania spp. and design of live recombinant salmonella vaccines against experimental visceral leishmaniasis

  2011cites this paper
• Estudo da imunogenicidade de vacinas de Mycobacterium smegmatis recombinante, expressando o gene que codifica aproteína ácida ribossomal de Leishmania infantum (LiP0), contra a infecção por Leishmania chagasi em hamster

  2011cites this paper
• DNA vaccination with KMP11 and Lutzomyia longipalpis salivary protein protects hamsters against visceral leishmaniasis.

  2011cites this paper
• Evaluation of Toxoplasma gondii as a live vaccine vector in susceptible and resistant hosts

  2011cites this paper
• Vaccine candidates for leishmaniasis: a review.

  2011cites this paper
• Kinetoplastid membrane protein-11 is present in promastigotes and amastigotes of Leishmania amazonensis and its surface expression increases during metacyclogenesis.

  2010cites this paper
• Utilisation de toxoplasma et de compositions dérivées pour prévenir ou traiter des infections microbiennes

  2010cites this paper
• Production of recombinant proteins from protozoan parasites.

  2010cites this paper
• Natural CD4+ T‐cell responses against Trypanosoma cruzi KMP‐11 protein in chronic chagasic patients

  2009cites this paper
• VACCINATION STRATEGIES AGAINST VISCERAL AND CUTANEOUS LEISHMANIASIS : LESSONS FROM THE EXPERIMENTAL MODELS

  2009cites this paper
• Searching genes encoding Leishmania antigens for diagnosis and protection

  2009cites this paper
• Recent developments in leishmaniasis vaccine delivery systems

  2008cites this paper
• Vaccines for leishmaniasis in the fore coming 25 years.

  2008cites this paper
• IMMUNOLOGICAL EFFECTS OF LEISHMANIA MAJOR SECRETORY AND EXCRETORY PRODUCTS ON CUTANEOUS LEISHMANIASIS IN BALB/C MICE

  2007cites this paper
• Approaches for the identification of potential excreted/secreted proteins of Leishmania major parasites

  2006cites this paper
• In vitro responses of human peripheral blood mononuclear cells to whole‐cell, particulate and soluble extracts of Leishmania promastigotes

  2006cites this paper
• Evaluation of IFN‐γ production by CD8+ T lymphocytes in response to the K1 peptide from KMP‐11 protein in patients infected with Trypanosoma cruzi

  2006cites this paper
• Evaluation of Oxidative Stress in Cutaneous Leishmaniasis

  2005cites this paper
• Studien zur DNA-Vakzinierung von Hühnern mit Eimeria tenella-Antigenen

  2005cites this paper
• Identification and delivery of immunodominant antigens of Neospora caninum

  2005cites this paper
• Immunological Responses and the Pattern of Disease in Mice Infected with Transfected Leishmania major Constitutively Expressing Active IL-1α

  2005cites this paper
• Molecular characterization of the kinetoplastid membrane protein-11 genes from the parasite Trypanosoma rangeli

  2005cites this paper
• Recent advances in vaccines for leishmaniasis

  2004cites this paper
• KMP-11: proteína 11 de Membrana de Kinetoplástidos

  2004cites this paper
• Localización cromosómica de los genes KMP-11 en cepas KP1(+) y KP1 (-) de Trypanosoma rangeli

  2004cites this paper
• Produit de traitement des infections par leishmania

  2004cites this paper
• Centromere, kinetochore, kinochore, kinetosome, kinosome, kinetomere, kinomere, kinetocentre, kinocentre: history, etymology and intepretation

  2003cites this paper
• Present status of antileishmanial vaccines

  2003cites this paper
• Molecularly Defined Antigens DC-Derived IL-12 and Can Be Induced by Uponan Intracellular Pathogen Is Dependent Dendritic Cell ( DC )-Based Protection Against

  2003cites this paper
• Leishmania mexicana and Leishmania major: attenuation of wild-type parasites and vaccination with the attenuated lines.

  2003cites this paper